We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,052 results
  1. Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains

    The aggregation, mislocalization, and phosphorylation of TDP-43 are pathologic hallmarks of several neurodegenerative diseases and provide a defining...

    Mingee Chung, E. Kathleen Carter, ... Zachary T. McEachin in Acta Neuropathologica
    Article Open access 03 February 2024
  2. Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer’s disease

    Nuclear clearance and cytoplasmic accumulations of the RNA-binding protein TDP-43 are pathological hallmarks in almost all patients with amyotrophic...

    Ana Rita Agra Almeida Quadros, Zhaozhi Li, ... Clotilde Lagier-Tourenne in Acta Neuropathologica
    Article Open access 04 January 2024
  3. RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS

    TDP-43 is an aggregation-prone protein which accumulates in the hallmark pathological inclusions of amyotrophic lateral sclerosis (ALS). However, the...

    Holly Spence, Fergal M. Waldron, ... Jenna M. Gregory in Acta Neuropathologica
    Article Open access 05 March 2024
  4. Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum

    The C9ORF72 -linked diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are characterized by the nuclear depletion and...

    Lauren M. Gittings, Eric B. Alsop, ... Kendall Van Keuren-Jensen in Acta Neuropathologica
    Article Open access 19 July 2023
  5. HnRNP K mislocalisation is a novel protein pathology of frontotemporal lobar degeneration and ageing and leads to cryptic splicing

    Heterogeneous nuclear ribonucleoproteins (HnRNPs) are a group of ubiquitously expressed RNA-binding proteins implicated in the regulation of all...

    Alexander Bampton, Ariana Gatt, ... Tammaryn Lashley in Acta Neuropathologica
    Article Open access 18 July 2021
  6. High-resolution structural variant profiling of myelodysplastic syndromes by optical genome map** uncovers cryptic aberrations of prognostic and therapeutic significance

    Chromosome banding analysis (CBA) remains the standard-of-care for structural variant (SV) assessment in MDS. Optical genome map** (OGM) is a...

    Hui Yang, Guillermo Garcia-Manero, ... Rashmi Kanagal-Shamanna in Leukemia
    Article Open access 01 August 2022
  7. Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion

    The most prominent genetic cause of both amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) is a repeat expansion in...

    Evan Udine, Mariely DeJesus-Hernandez, ... Marka van Blitterswijk in Acta Neuropathologica
    Article Open access 19 April 2024
  8. Characterization of NEB pathogenic variants in patients reveals novel nemaline myopathy disease mechanisms and omecamtiv mecarbil force effects

    Nebulin, a critical protein of the skeletal muscle thin filament, plays important roles in physiological processes such as regulating thin filament...

    Esmat Karimi, Jochen Gohlke, ... Henk Granzier in Acta Neuropathologica
    Article Open access 18 April 2024
  9. Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer’s disease neuropathologic changes and cognitive decline

    LATE-NC, the neuropathologic changes of limbic-predominant age-related TAR DNA-binding protein 43 kDa (TDP-43) encephalopathy are frequently...

    Ko** Chang, Jonathan P. Ling, ... Juan C. Troncoso in Acta Neuropathologica
    Article 22 December 2023
  10. Identification of a Novel Homozygous GLS Gene Variant Associated with Developmental and Epileptic Encephalopathy (DEE) Type 71

    Developmental and epileptic encephalopathy (DEEs) (OMIM#618,328) is characterized by seizures, hypotonia, and brain abnormalities, often arising from...

    Afsaneh Bazgir, Mehdi Agha Gholizadeh, ... Masoud Garshasbi in Neurogenetics
    Article 15 April 2024
  11. All reported non-canonical splice site variants in GLA cause aberrant splicing

    Background

    Fabry disease is an X-linked lysosomal storage disorder caused by insufficient α-galactosidase A (GLA) activity resulting from variants in...

    Eri Okada, Tomoko Horinouchi, ... Kandai Nozu in Clinical and Experimental Nephrology
    Article Open access 31 May 2023
  12. Aberrant splicing caused by exonic single nucleotide variants positioned 2nd or 3rd to the last nucleotide in the COL4A5 gene

    Background and objectives

    The evident genotype–phenotype correlation shown by the X-linked Alport syndrome warrants the assessment of the impact of...

    Eri Okada, Yuya Aoto, ... Kandai Nozu in Clinical and Experimental Nephrology
    Article Open access 12 November 2022
  13. Comprehensive characterisation of intronic mis-splicing mutations in human cancers

    Previous studies studying mis-splicing mutations were based on exome data and thus our current knowledge is largely limited to exons and the...

    Hyunchul Jung, Kang Seon Lee, Jung Kyoon Choi in Oncogene
    Article Open access 08 January 2021
  14. Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma

    Histone H3 mutations at amino acids 27 (H3K27M) and 34 (H3G34R) are recurrent drivers of pediatric-type high-grade glioma (pHGG). H3K27M mutations...

    Robert Siddaway, Laura Canty, ... Cynthia Hawkins in Acta Neuropathologica
    Article Open access 07 September 2022
  15. ALK detection in lung cancer: identification of atypical and cryptic ALK rearrangements using an optimal algorithm

    Purpose

    IHC, FISH, and NGS are common methods of ALK evaluation in NSCLC. The purpose of this study was to investigate whether ALK false positives or...

    Yuanyuan Liu, Shafei Wu, ... Xuan Zeng in Journal of Cancer Research and Clinical Oncology
    Article 03 March 2020
  16. Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia

    New methods like panel-based RNA fusion sequencing (RNA-FS) promise improved diagnostics in various malignancies. We here analyzed the impact of...

    Lina Marie Hoffmeister, Julia Suttorp, ... Markus Schneider in Leukemia
    Article Open access 12 December 2023
  17. Backtracking NOM1::ETV6 fusion to neonatal pathogenesis of t(7;12) (q36;p13) infant AML

    Pablo Bousquets-Muñoz, Oscar Molina, ... Talia Velasco-Hernandez in Leukemia
    Article Open access 28 May 2024
  18. Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders

    Antisense oligonucleotides (ASOs) are incredibly versatile molecules that can be designed to specifically target and modify RNA transcripts to slow...

    Marlen C. Lauffer, Willeke van Roon-Mom, Annemieke Aartsma-Rus in Communications Medicine
    Article Open access 05 January 2024
  19. Clinical and genetic characteristics of Tunisian children with infantile nephropathic cystinosis

    Background

    Nephropathic cystinosis is an autosomal recessive disease caused by a mutation in the CTNS gene which encodes cystinosin, a lysosomal...

    Mariem El Younsi, Médiha Trabelsi, ... Ridha M’rad in Pediatric Nephrology
    Article 20 April 2022
Did you find what you were looking for? Share feedback.